• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病控制状况对帕金森病进展的影响:一项前瞻性研究。

Effect of diabetes control status on the progression of Parkinson's disease: A prospective study.

机构信息

Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

出版信息

Ann Clin Transl Neurol. 2021 Apr;8(4):887-897. doi: 10.1002/acn3.51343. Epub 2021 Mar 25.

DOI:10.1002/acn3.51343
PMID:33764699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8045952/
Abstract

OBJECTIVE

To evaluate whether the control status of type 2 diabetes mellitus (DM) influences the progression of Parkinson's disease (PD).

METHODS

We conducted a prospective cohort study from March 2009 to August 2020. Patients at baseline were categorized into DM and non-DM groups, and those with DM were further classified into the well and poorly controlled DM groups based on the 7.0% of glycated hemoglobin (HbA1C) levels. Multivariate Cox proportional hazards regression models were used to explore the predictors for PD-related outcomes by hazard ratios (HRs) and 95% confidence intervals (CIs).

RESULTS

Of the 379 patients enrolled, 49 (12.9%) had DM, and 22 of DM (44.9%) were poorly controlled. The adjusted HRs were 2.060 (95% CI 1.165-3.641) for United Rating Scale (UPDRS) III score increased ≥14 in the poorly controlled-DM group, and 1.066 (95% CI 0.572-1.986) in the well-controlled DM group, relative to the non-DM group (p trend = 0.025), after adjusting for sex, age, age of onset, body mass index, and UPDRS III and Montreal Cognitive Assessment (MoCA) scores at baseline. The adjusted HRs were 2.079 (95% CI 1.212-3.566) for reaching Hoehn & Yahr stage ≥3 in the poorly controlled DM group, and 0.879 (95% CI 0.413-1.871) in the well-controlled DM group, compared with the non-DM group (p trend = 0.021). Time to death or time to MoCA 3-point decrease were not significantly different among the three groups.

INTERPRETATION

Poorly controlled DM is an independent risk factor contributing to motor progression in PD. Our study highlights the importance of adequate control of diabetes in PD.

摘要

目的

评估 2 型糖尿病(DM)的控制状况是否会影响帕金森病(PD)的进展。

方法

我们进行了一项从 2009 年 3 月至 2020 年 8 月的前瞻性队列研究。基线时的患者被分为 DM 和非 DM 组,根据糖化血红蛋白(HbA1C)水平的 7.0%,DM 患者进一步分为 DM 控制良好和控制不佳两组。使用多变量 Cox 比例风险回归模型,通过风险比(HR)和 95%置信区间(CI)探索 PD 相关结局的预测因素。

结果

在纳入的 379 名患者中,有 49 名(12.9%)患有 DM,其中 22 名(44.9%)DM 控制不佳。调整性别、年龄、发病年龄、体重指数以及基线时 UPDRS III 评分和蒙特利尔认知评估(MoCA)评分后,与非 DM 组相比,控制不佳 DM 组的 UPDRS III 评分增加≥14 的调整 HR 为 2.060(95%CI 1.165-3.641),控制良好 DM 组为 1.066(95%CI 0.572-1.986)(p 趋势=0.025)。调整性别、年龄、发病年龄、体重指数以及基线时 UPDRS III 评分和 MoCA 评分后,与非 DM 组相比,控制不佳 DM 组的 Hoehn & Yahr 分期≥3 的调整 HR 为 2.079(95%CI 1.212-3.566),控制良好 DM 组为 0.879(95%CI 0.413-1.871)(p 趋势=0.021)。三组患者的死亡时间或 MoCA 评分下降 3 分的时间无显著差异。

结论

控制不佳的 DM 是 PD 运动进展的独立危险因素。我们的研究强调了在 PD 中充分控制糖尿病的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0485/8045952/663ad4356f63/ACN3-8-887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0485/8045952/cb46f0883d22/ACN3-8-887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0485/8045952/22f8528e3d79/ACN3-8-887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0485/8045952/663ad4356f63/ACN3-8-887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0485/8045952/cb46f0883d22/ACN3-8-887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0485/8045952/22f8528e3d79/ACN3-8-887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0485/8045952/663ad4356f63/ACN3-8-887-g001.jpg

相似文献

1
Effect of diabetes control status on the progression of Parkinson's disease: A prospective study.糖尿病控制状况对帕金森病进展的影响:一项前瞻性研究。
Ann Clin Transl Neurol. 2021 Apr;8(4):887-897. doi: 10.1002/acn3.51343. Epub 2021 Mar 25.
2
Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.帕金森病患者体重指数变化、统一帕金森病评定量表评分与生存率之间的关联:国立神经疾病和中风研究所帕金森病长期研究1探索性试验纵向数据的二次分析
JAMA Neurol. 2016 Mar;73(3):321-8. doi: 10.1001/jamaneurol.2015.4265.
3
Impact of diabetes and glycated hemoglobin level on the clinical manifestations of Parkinson's disease.糖尿病和糖化血红蛋白水平对帕金森病临床表现的影响。
J Neurol Sci. 2023 Nov 15;454:120851. doi: 10.1016/j.jns.2023.120851. Epub 2023 Nov 3.
4
Diabetes, Glycated Hemoglobin (HbA1c), and Neuroaxonal Damage in Parkinson's Disease (MARK-PD Study).糖尿病、糖化血红蛋白 (HbA1c) 与帕金森病的神经轴索损伤(MARK-PD 研究)。
Mov Disord. 2022 Jun;37(6):1299-1304. doi: 10.1002/mds.29009. Epub 2022 Apr 6.
5
Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study.非酒精性脂肪性肝病的临床可用性作为韩国男性 2 型糖尿病的早期预测指标:一项 5 年前瞻性队列研究。
Hepatology. 2013 Apr;57(4):1378-83. doi: 10.1002/hep.26183.
6
Diabetes Mellitus and Parkinson's Disease: A Systematic Review and Meta-Analyses.糖尿病与帕金森病:系统评价和荟萃分析。
J Parkinsons Dis. 2021;11(4):1585-1596. doi: 10.3233/JPD-212725.
7
Multiple Evidences for Association between Cognitive Impairment and Dysglycemia in Parkinson's Disease: Implications for Clinical Practice.帕金森病中认知障碍与血糖异常之间关联的多重证据:对临床实践的启示
Front Aging Neurosci. 2017 Nov 3;9:355. doi: 10.3389/fnagi.2017.00355. eCollection 2017.
8
Euglycemia Indicates Favorable Motor Outcome in Parkinson's Disease.血糖正常表明帕金森病的运动预后良好。
Mov Disord. 2021 Jun;36(6):1430-1434. doi: 10.1002/mds.28545. Epub 2021 Feb 26.
9
Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.早期帕金森病疾病进展的测量:美国国立卫生研究院帕金森病探索性试验(NET-PD)的经验。
JAMA Neurol. 2014 Jun;71(6):710-6. doi: 10.1001/jamaneurol.2014.391.
10
Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.多基因风险评分与帕金森病认知下降和运动进展的关系。
JAMA Neurol. 2018 Mar 1;75(3):360-366. doi: 10.1001/jamaneurol.2017.4206.

引用本文的文献

1
Effects of Diabetes Mellitus on Motor and Non-Motor Symptoms in Parkinson's Disease: A Cross-Sectional Study.糖尿病对帕金森病运动和非运动症状的影响:一项横断面研究。
Rev Neurol. 2025 Aug 27;80(7):38630. doi: 10.31083/RN38630.
2
The Influence of Insulin Resistance and Type 2 Diabetes on Cognitive Decline and Dementia in Parkinson's Disease: A Systematic Review.胰岛素抵抗和2型糖尿病对帕金森病认知功能减退和痴呆的影响:一项系统评价
Int J Mol Sci. 2025 Aug 21;26(16):8078. doi: 10.3390/ijms26168078.
3
Exploring Risk and Protective Factors in Parkinson's Disease.

本文引用的文献

1
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa).帕金森病队列研究(DeNoPa)中帕金森病确诊后 4 年进展的基线预测因子。
Mov Disord. 2019 Jan;34(1):67-77. doi: 10.1002/mds.27492. Epub 2018 Nov 23.
2
Earlier onset of motor complications in Parkinson's patients with comorbid diabetes mellitus.合并糖尿病的帕金森病患者运动并发症的发病时间更早。
Mov Disord. 2018 Dec;33(12):1967-1968. doi: 10.1002/mds.27526. Epub 2018 Nov 14.
3
Detrimental effect of type 2 diabetes mellitus in a large case series of Parkinson's disease.
探索帕金森病的风险因素和保护因素。
Cells. 2025 May 14;14(10):710. doi: 10.3390/cells14100710.
4
Impact of diabetes mellitus type two on incidence and progression of Parkinson's disease: a systematic review of longitudinal patient cohorts.2型糖尿病对帕金森病发病率和进展的影响:纵向患者队列的系统评价
J Neural Transm (Vienna). 2025 May;132(5):627-635. doi: 10.1007/s00702-025-02882-7. Epub 2025 Jan 23.
5
Metabolism and metabolomics in senescence, aging, and age-related diseases: a multiscale perspective.衰老、老化及年龄相关疾病中的代谢与代谢组学:多尺度视角
Front Med. 2025 Apr;19(2):200-225. doi: 10.1007/s11684-024-1116-0. Epub 2025 Jan 17.
6
Understanding the link between type 2 diabetes mellitus and Parkinson's disease: role of brain insulin resistance.理解2型糖尿病与帕金森病之间的联系:脑胰岛素抵抗的作用。
Neural Regen Res. 2025 Nov 1;20(11):3113-3123. doi: 10.4103/NRR.NRR-D-23-01910. Epub 2024 Apr 3.
7
The Interplay of Stress, Inflammation, and Metabolic Factors in the Course of Parkinson's Disease.应激、炎症和代谢因素在帕金森病病程中的相互作用。
Int J Mol Sci. 2024 Nov 19;25(22):12409. doi: 10.3390/ijms252212409.
8
Untargeted serum metabolic profiling of diabetes mellitus among Parkinson's disease patients.帕金森病患者糖尿病的非靶向血清代谢谱分析
NPJ Parkinsons Dis. 2024 May 10;10(1):100. doi: 10.1038/s41531-024-00711-4.
9
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.2型糖尿病对帕金森病病因的影响。
Int J Mol Sci. 2024 Apr 15;25(8):4358. doi: 10.3390/ijms25084358.
10
Hyperglycemia affects axial signs in patients with Parkinson's disease through mechanisms of insulin resistance or non-insulin resistance.高血糖通过胰岛素抵抗或非胰岛素抵抗机制影响帕金森病患者的轴性体征。
Neurol Sci. 2024 May;45(5):2011-2019. doi: 10.1007/s10072-023-07273-y. Epub 2023 Dec 26.
2 型糖尿病对帕金森病大病例系列的不良影响。
Parkinsonism Relat Disord. 2019 Jul;64:54-59. doi: 10.1016/j.parkreldis.2018.08.023. Epub 2018 Aug 31.
4
Glucose dysregulation in Parkinson's disease: Too much glucose or not enough insulin?帕金森病中的葡萄糖代谢紊乱:是葡萄糖过多还是胰岛素不足?
Parkinsonism Relat Disord. 2018 Oct;55:122-127. doi: 10.1016/j.parkreldis.2018.05.026. Epub 2018 May 31.
5
Diabetes mellitus and Parkinson disease.糖尿病与帕金森病。
Neurology. 2018 May 8;90(19):e1654-e1662. doi: 10.1212/WNL.0000000000005475. Epub 2018 Apr 6.
6
Diabetes and Parkinson disease: A sweet spot?糖尿病与帕金森病:一个契合点?
Neurology. 2018 May 8;90(19):869-870. doi: 10.1212/WNL.0000000000005470. Epub 2018 Apr 6.
7
Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival.血红蛋白 A1c 水平与肌萎缩侧索硬化症的生存。
Mol Neurodegener. 2017 Sep 21;12(1):69. doi: 10.1186/s13024-017-0211-y.
8
6. Glycemic Targets.6. 血糖目标。
Diabetes Care. 2017 Jan;40(Suppl 1):S48-S56. doi: 10.2337/dc17-S009.
9
Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients.糖化血红蛋白(HbA1c)检测在糖尿病患者诊断及预后中的意义
Biomark Insights. 2016 Jul 3;11:95-104. doi: 10.4137/BMI.S38440. eCollection 2016.
10
Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.糖尿病患者患帕金森病的风险:基于人群队列研究的最新荟萃分析
Medicine (Baltimore). 2016 May;95(18):e3549. doi: 10.1097/MD.0000000000003549.